Meeting randomization & clinical supply challenges head-on
Publié le
Strategic partnership to pair long-standing clinical research expertise with a best-in-class RTSM system
Adapting the Randomization Algorithm
Publié le
Discover how IDDI biostatistics-driven RTSM helped the Sponsor to avoid serious imbalance between the two randomized arms for the treated…
Adding a stratification factor during the study
Publié le
Discover how a Sponsor reached the overall balance amongst 2 arms by adding a stratification factor.
Optimizing the Drug Supply Strategy
Publié le
Discover how a Sponsor optimized the drug delivery via IDDI’s Proposition of a Predictive Drug Supply Model. PLEASE FILL IN…
Happy Holiday Season
Publié le
Happy Holiday Season from the IDDI team Thank you for all your support throughout the year. Wishing you…
Why do so Many Phase III Fail?
Publié le
Randomized controlled trials (RCTs), particularly in phase 3, are the preferred sources of evidence for drug approval and reimbursement decisions….
Generalized Pairwise Comparisons – GPC
Publié le
AN INNOVATIVE STATISTICAL METHOD PAVING THE WAY TO PERSONALIZED MEDICINE The method of Generalized Pairwise Comparisons (GPC) fulfills a recent literature trend…
AN INNOVATIVE STATISTICAL METHODOLOGY
Publié le
Generalized Pairwise Comparisons – GPC Today’s session is focusing on an innovative statistical methodology called Generalized Pairwise Comparisons – or…
IDDI announces RTSM partnership with Clario
Publié le
PRESS RELEASE Clario to deliver industry leading Randomization, Trial Supply and Management SaaS for new partnership with IDDI Use of…
Statistical Programmer
Publié le
IDDI (International Drug Development Institute), founded in 1991, is a highly recognized biostatistical and eClinical data service provider in the…